tiprankstipranks
Vertex Pharmaceuticals Inc. (MX:VRTX)
NASDAQ:VRTX
Mexico Market
VRTX
Vertex Pharmaceuticals
RESEARCH TOOLSreports

Vertex Pharmaceuticals (VRTX) Ratios

0 Followers

Vertex Pharmaceuticals Ratios

MX:VRTX's free cash flow for Q2 2026 was $0.85. For the 2026 fiscal year, MX:VRTX's free cash flow was decreased by $ and operating cash flow was $0.42. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.19 2.90 2.69 3.99 4.83
Quick Ratio
 2.74 2.46 2.35 3.78 4.66
Cash Ratio
 1.56 1.32 1.28 2.92 3.83
Solvency Ratio
 0.64 0.56 -0.05 0.74 0.82
Operating Cash Flow Ratio
 1.09 0.94 -0.14 1.00 1.51
Short-Term Operating Cash Flow Coverage
 0.00 43.86 -5.34 0.00 0.00
Net Current Asset Value
$ 5.37B$ 3.72B$ 3.47B$ 8.99B$ 9.00B
Leverage Ratios
Debt-to-Assets Ratio
 0.07 0.15 0.08 0.04 0.05
Debt-to-Equity Ratio
 0.10 0.21 0.11 0.05 0.06
Debt-to-Capital Ratio
 0.09 0.17 0.10 0.04 0.06
Long-Term Debt-to-Capital Ratio
 0.00 0.09 0.00 0.00 0.00
Financial Leverage Ratio
 1.35 1.40 1.37 1.29 1.30
Debt Service Coverage Ratio
 693.21 43.43 -2.42 87.19 64.33
Interest Coverage Ratio
 738.18 357.95 -7.61 86.89 78.60
Debt to Market Cap
 0.00 0.02 <0.01 0.00 0.00
Interest Debt Per Share
 7.81 15.24 6.91 3.31 3.73
Net Debt to EBITDA
 -0.77 -0.25 -5.80 -2.08 -2.17
Profitability Margins
Gross Profit Margin
86.04%85.03%86.11%87.21%87.90%
EBIT Margin
41.84%38.56%2.53%44.83%48.01%
EBITDA Margin
43.13%40.28%4.41%46.66%49.67%
Operating Profit Margin
38.59%39.43%-2.11%38.83%48.23%
Pretax Profit Margin
41.78%38.45%2.25%44.38%47.39%
Net Profit Margin
34.89%32.74%-4.86%36.68%37.20%
Continuous Operations Profit Margin
34.90%32.74%-4.86%36.68%37.20%
Net Income Per EBT
83.51%85.14%-215.53%82.64%78.49%
EBT Per EBIT
108.27%97.53%-106.70%114.30%98.26%
Return on Assets (ROA)
16.06%15.12%-2.38%15.92%18.30%
Return on Equity (ROE)
23.31%21.18%-3.26%20.59%23.88%
Return on Capital Employed (ROCE)
20.74%21.37%-1.23%19.98%27.95%
Return on Invested Capital (ROIC)
17.33%18.12%2.63%16.44%21.81%
Return on Tangible Assets
16.99%16.05%-2.60%17.40%20.18%
Earnings Yield
3.37%3.41%-0.52%3.45%4.49%
Efficiency Ratios
Receivables Turnover
 5.91 5.88 6.85 6.31 6.19
Payables Turnover
 4.10 3.91 3.71 3.46 3.55
Inventory Turnover
 1.00 1.07 1.27 1.71 2.35
Fixed Asset Turnover
 3.79 3.92 4.26 6.79 6.13
Asset Turnover
 0.46 0.46 0.49 0.43 0.49
Working Capital Turnover Ratio
 1.53 1.81 1.33 0.94 1.00
Cash Conversion Cycle
 338.25 309.50 242.28 165.94 111.89
Days of Sales Outstanding
 61.71 62.05 53.31 57.82 58.94
Days of Inventory Outstanding
 365.48 340.70 287.47 213.64 155.62
Days of Payables Outstanding
 88.93 93.25 98.49 105.52 102.68
Operating Cycle
 427.18 402.76 340.77 271.46 214.57
Cash Flow Ratios
Operating Cash Flow Per Share
 16.91 14.20 -1.91 13.73 16.13
Free Cash Flow Per Share
 14.95 12.49 -3.07 12.72 15.33
CapEx Per Share
 1.96 1.71 1.16 1.00 0.80
Free Cash Flow to Operating Cash Flow
 0.88 0.88 1.60 0.93 0.95
Dividend Paid and CapEx Coverage Ratio
 8.64 8.30 -1.65 13.69 20.18
Capital Expenditure Coverage Ratio
 8.64 8.30 -1.65 13.69 20.18
Operating Cash Flow Coverage Ratio
 2.17 0.94 -0.28 4.38 4.59
Operating Cash Flow to Sales Ratio
 0.34 0.30 -0.04 0.36 0.46
Free Cash Flow Yield
2.90%2.76%-0.76%3.13%5.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 29.77 29.32 -193.61 28.97 22.26
Price-to-Sales (P/S) Ratio
 10.36 9.60 9.41 10.62 8.28
Price-to-Book (P/B) Ratio
 6.46 6.21 6.32 5.96 5.32
Price-to-Free Cash Flow (P/FCF) Ratio
 34.47 36.30 -131.21 31.98 18.84
Price-to-Operating Cash Flow Ratio
 30.49 31.92 -210.51 29.64 17.91
Price-to-Earnings Growth (PEG) Ratio
 1.32 -0.03 1.69 3.48 0.52
Price-to-Fair Value
 6.46 6.21 6.32 5.96 5.32
Enterprise Value Multiple
 23.27 23.59 207.43 20.69 14.51
Enterprise Value
 126.68B 114.72B 100.88B 95.29B 64.35B
EV to EBITDA
 23.27 23.59 207.43 20.69 14.51
EV to Sales
 10.03 9.50 9.15 9.66 7.21
EV to Free Cash Flow
 33.37 35.92 -127.64 29.06 16.39
EV to Operating Cash Flow
 29.51 31.59 -204.78 26.94 15.58
Tangible Book Value Per Share
 73.84 67.08 56.29 60.74 47.72
Shareholders’ Equity Per Share
 79.75 73.00 63.73 68.22 54.33
Tax and Other Ratios
Effective Tax Rate
 0.16 0.15 3.16 0.17 0.22
Revenue Per Share
 49.72 47.22 42.80 38.30 34.87
Net Income Per Share
 17.35 15.46 -2.08 14.05 12.97
Tax Burden
 0.84 0.85 -2.16 0.83 0.78
Interest Burden
 1.00 1.00 0.89 0.99 0.99
Research & Development to Revenue
 0.31 0.31 0.33 0.32 0.30
SG&A to Revenue
 0.16 0.15 0.13 0.00 0.00
Stock-Based Compensation to Revenue
 0.05 0.06 0.06 0.06 0.06
Income Quality
 0.97 0.92 0.92 0.98 1.24
Currency in USD